Table 3 Symptom prevalence and adjusted prevalence ratio by exposure zone
Symptom | Exposure Zone | Prevalence % (95% CI) | Adjusted prevalence ratioa (95% CI) |
|---|---|---|---|
Dry Eye | High | 7.1 (3.8 – 10.5) | 1.12 (0.62 – 2.02) |
Medium | 7.5 (3.4 – 11.5) | 1.11 (0.59 – 2.06) | |
Low | 6.3 (3.9 – 8.7) | 1.00 | |
Overall | 6.6 (4.7 – 8.6) | ||
Any Eye Symptom | High | 51.6 (43.8 – 59.5) | 1.11 (0.92–1.34) |
Medium | 57.3 (50.6 – 64.1) | 1.23 (1.05–1.45) | |
Low | 47.1 (41.8 – 52.4) | 1.00 | |
Overall | 50.0 (46.0 – 54.0) | ||
More Frequent and/or Severe Eye Symptom | High | 15.0 (10.2 – 19.7) | 0.95 (0.64–1.40) |
Medium | 21.3 (15.4 – 27.1) | 1.28 (0.89–1.83) | |
Low | 16.0 (12.2 – 19.8) | 1.00 | |
Overall | 17.2 (14.2 – 20.1) | ||
Any Nasal Symptom | High | 60.3 (52.4 – 68.2) | 0.90 (0.77–1.04) |
Medium | 67.4 (61.0 – 73.9) | 1.01 (0.89–1.14) | |
Low | 67.2 (62.2 – 72.2) | 1.00 | |
Overall | 66.6 (62.9–70.4) | ||
More Frequent and/or Severe Nasal Symptom | High | 30.8 (24.0 – 37.7) | 1.00 (0.76–1.31) |
Medium | 38.2 (31.4 – 45.0) | 1.20 (0.96–1.52) | |
Low | 31.2 (26.5 – 36.0) | 1.00 | |
Overall | 32.9 (29.2–36.6) | ||
Any Throat Symptom | High | 31.0 (23.4 – 38.6) | 0.96 (0.73–1.28) |
Medium | 32.9 (26.5 – 39.3) | 1.01 (0.79–1.30) | |
Low | 33.5 (28.4 – 38.6) | 1.00 | |
Overall | 33.1 (29.3–36.9) | ||
More Frequent and/or Severe Throat Symptom | High | 13.7 (9.0 – 18.4) | 0.97 (0.63–1.49) |
Medium | 15.7 (10.7 – 20.6) | 1.07 (0.72–1.59) | |
Low | 14.8 (11.1 – 18.5) | 1.00 | |
Overall | 14.9 (12.1–17.7) |